Endometrial polyps in pre-and postmenopausal women: Factors associated with malignancy

Maturitas

Volumn 59, Issue 1, 2008, Pages 99-100

  Cohen, Ilan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

BREAST CANCER; CANCER HORMONE THERAPY; CLINICAL FEATURE; ENDOMETRIUM CANCER; ENDOMETRIUM POLYP; HUMAN; LETTER; MALIGNANT TRANSFORMATION; POSTMENOPAUSE; PREMENOPAUSE; TREATMENT OUTCOME;

CELL TRANSFORMATION, NEOPLASTIC; ENDOMETRIAL NEOPLASMS; ESTROGEN RECEPTOR MODULATORS; FEMALE; HUMANS; POLYPS; POSTMENOPAUSE; PREMENOPAUSE; TAMOXIFEN;

EID: 38749144747     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2007.08.005     Document Type: Letter

References (6)

1. Antunes Jr. A., Costa-pavia L., Arthuso M., Costa J.V., and Pinto-Neto A.M. Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy. Maturitas 57 (2007) 415-421
2. Cohen I., Bernheim J., Azaria R., Tepper R., Sharoney R., and Beyth Y. Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients. Gynecol Oncol 75 (1999) 136-141
3. Berleire M., Charles A., Galant C., and Donnez J. Uterine side effects of tamoxifen: a need for systemic pretreatment screening. Obstet Gynecol 91 (1998) 40-44
4. Schlesinger C., Kamol S., Ascher S., Kendell M., Lage M., and Siverberg S.G. Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups. Int J Gynecol Pathol 17 (1998) 302-311
5. Ramondetta L.M., Sherwood J.B., Dunton J.D., and Palazzo J.P. Endometrial cancer in polyps associated with tamoxifen use. Am J Obstet Gynecol 180 (1999) 340-341
6. Deligdisch L., Kalir N., Cohen C.J., de Latour M., Le Bouedec G., and Penault-Llorca F. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer. Gynecol Oncol 78 (2000) 181-186